Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Andrews

Showing results (991-1000 of 1,095) with videos related to

Pageof 110
Sort By:
Journal of Medicinal Chemistry|February 20, 2004
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1Joseph H Chan, George A Freeman, Jeffrey H Tidwell, et al.
The Journal of Nutrition|June 29, 2019
The Dietary Supplement Label Database: Recent Developments and ApplicationsJohanna T Dwyer, Richard A Bailen, Leila G Saldanha, et al.
Nature|February 6, 2023
Universal logic with encoded spin qubits in siliconAaron J Weinstein, Matthew D Reed, Aaron M Jones, et al.
Nature Medicine|October 29, 2013
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancerA Vaishnavi, M Capelletti, A T Le, et al.
Plos Neglected Tropical Diseases|October 5, 2020
Trypanosomatid selenophosphate synthetase structure, function and interaction with selenocysteine lyaseMarco Túlio Alves da Silva, Ivan Rosa E Silva, Lívia Maria Faim, et al.
Future Oncology (London, England)|December 7, 2023
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patientsIan Y Lee, Simon Hanft, Michael Schulder, et al.
British Journal of Pharmacology|August 22, 2000
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compoundsD F Woodward, A H Krauss, J Chen, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2008
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)Scott D Seiwert, Steven W Andrews, Yutong Jiang, et al.
Open Biology|December 17, 2024
Small molecule protein assembly modulators with pan-cancer therapeutic efficacyAnuradha F Lingappa, Olayemi Akintunde, Erin Samueli, et al.
Pageof 110

Showing results (991-1000 of 1,095) with videos related to

Sort By:
Pageof 110
Journal of Medicinal Chemistry|February 20, 2004
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1Joseph H Chan, George A Freeman, Jeffrey H Tidwell, et al.
The Journal of Nutrition|June 29, 2019
The Dietary Supplement Label Database: Recent Developments and ApplicationsJohanna T Dwyer, Richard A Bailen, Leila G Saldanha, et al.
Nature|February 6, 2023
Universal logic with encoded spin qubits in siliconAaron J Weinstein, Matthew D Reed, Aaron M Jones, et al.
Nature Medicine|October 29, 2013
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancerA Vaishnavi, M Capelletti, A T Le, et al.
Plos Neglected Tropical Diseases|October 5, 2020
Trypanosomatid selenophosphate synthetase structure, function and interaction with selenocysteine lyaseMarco Túlio Alves da Silva, Ivan Rosa E Silva, Lívia Maria Faim, et al.
Future Oncology (London, England)|December 7, 2023
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patientsIan Y Lee, Simon Hanft, Michael Schulder, et al.
British Journal of Pharmacology|August 22, 2000
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compoundsD F Woodward, A H Krauss, J Chen, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2008
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)Scott D Seiwert, Steven W Andrews, Yutong Jiang, et al.
Open Biology|December 17, 2024
Small molecule protein assembly modulators with pan-cancer therapeutic efficacyAnuradha F Lingappa, Olayemi Akintunde, Erin Samueli, et al.
Pageof 110